The occurrence of chromosome aberrations was studied In short-term cultured lymphocytes from nine workers exposed to arsenic at the Ronnskar smeltery in northern Sweden. In the smelter workers, 87 aberrations were found in 819 mitoses. The number of aberrations varied individually from 0 to 25 aberrations per 100 cells. In a control material 13 aberrations were found in 1012 mitoses. The frequency of chromosome aberrations was significantly increased among the smelter workers, but due to the simultaneous exposure to other agents the effect of arsenic per se can not be assessed with certainty.
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Carcinogenic effects of arsenic have been found in clinical and epidemiological investigations (1, 2), but not in animal experiments (3) . An increased frequency of chromosome aberrations has been found (4) in short-term cultured lymphocytes of wine growers and psoriatric patients treated with arsenic. Experimental studies (5) in Escherichia coli suggest that arsenic compounds may act as cocarcinogens by inhibiting DNA repair. In this paper we report some preliminary results from a study of chromosome aberrations in arsenic exposed workers at the Ronnkar smeltery in northern Sweden.
Materials and Methods
Blood samples were collected from a series of workers exposed to arsenic at the Ronnskar smeltery and sent to the Clinical Genetics laboratory in Umea for examination. This study is a part of a larger project involving exposition to other potentially hazardous agents at Ronnskar, e.g., lead. We are presenting here data for a relatively small number of individuals. The ongoing project will not be completed until next year.
Data on urinary arsenic levels and type and duration of exposition were available on most of the examined workers. As controls apparently healthy individuals from Ume'a were used. Other control material from newly employed workers at Ronnskar is now under collection.
*Department of Medical Genetics, University of Umea, Umea, Sweden.
Human lymphocytes were grown in vitro for a period of 68-70 hr according to a procedure described previously (6) .
Results and Discussion
The results are shown in The frequency of aberrations was significantly higher (p < 0.001) among the arsenic-exposed workers. All three types of aberrations, gaps (p < 0.001), chromatid aberrations (p <0.01), and chromosome aberrations (p < 0.001) were significantly increased. The individual variations were large: from 0 to 25 aberrations per 100 cells.
The exact meaning of this result is difficult to evaluate at this point of the investigation. There seems to be little doubt that there is a relationship between arsenic exposition and chromosome breakage, which also is in agreement with previous findings (4) . There was, however, no obvious relationship between exposure and frequency of aberrations in our material. Furthermore the individual with the highest frequency of aberrations had been exposed to arsenic, lead, and selenium. (Ronnskar is characterized by a multitude of potentially hazardous agents.) Therefore we feel that conclusions concerning the mutagenic-carcinogenic effect of arsenic per se should await further investigations. Thus a possible explanation (5) is that arsenic, by inhibiting DNA repair, may be deleterious mainly in combination with other agents. In cases of long-range suppression of DNA repair it is, of course, possible that the background mutagenicity may cause considerable cumulative chromosomal damage to cells with such a long life span as the lymphocytes.
